Albany Molecular Research
Dec 13, 2016

AMRI CEO to Present at 35th Annual J.P. Morgan Healthcare Conference

Albany, NY (December 13, 2016) – Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI’s President and Chief Executive Officer, will present at the 35th Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2017 at 10:30 a.m. PT, with a question and answer session to follow at 11:00 a.m. PT. A live audio webcast of the presentation and question and answer session can be accessed at AMRI’s Investor Relations web site at http://ir.amriglobal.com/events.cfm?CalendarID=2

The webcast will be archived for 90 days following the live presentation.
 

About AMRI
Albany Molecular Research Inc. (AMRI) is a global contract research and manufacturing organization that has been working with the Life Sciences industry to improve patient outcomes and the quality of life for more than two decades. With locations in North America, Europe and Asia, our key business segments include Discovery and Development Services (DDS), Active Pharmaceutical Ingredients (API), Drug Product (DP), and Fine Chemicals. For more information about AMRI, please visit our website at www.amriglobal.com or follow us on Twitter (@amriglobal).

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/amri-ceo-to-present-at-35th-annual-jp-morgan-healthcare-conference-300376673.html

SOURCE AMRI

 

 

News Provided by Acquire Media